Newsletter Subject

American Greed: Pot Promoter Commits Ultimate Trading Sin

From

biotechbreakouts.com

Email Address

kyle@biotechbreakouts.com

Sent On

Sun, Dec 15, 2019 05:13 PM

Email Preheader Text

You could go into Monday’s trading session… Dazed, confused, and lost...or… You could

You could go into Monday’s trading session… Dazed, confused, and lost...or… You could receive my highest-conviction trade idea — tomorrow. Each alert sent has been a winner thus far… what are you waiting for? [Watch Now]( Hello trader, Make no mistake about it, one of the fastest-growing sectors in the economy is marijuana. More states are easing their laws on cannabis, and who knows, it could be completely legal one day. But if you ask most traders, they’ll tell you they don’t care about all that. They see it as an opportunity to make a whole lot of money, nothing more, nothing less. That said, pot stocks have a wild reputation to tame. They’re volatile, and the recent selloff in these names makes it rather difficult to trade. Not only that, but shady pot stock promoters are rampant, and they only add fuel to that fire. I’ve actually come across a case that involves a pharmaceutical company ([one of my favorite sectors to profit from](). The story is about a stock promoter who preached the good words of this pot stock… and was paid handsomely to do so. Duping investors into buying up shares using their own hard-earned dollars. All while the friendly promoter was looking for the best time to dump his holdings. This case has cannabis companies and supporters in an uproar… and if you’re thinking about trading pharmaceutical or cannabis companies, you’ll want to take note and avoid these red flags... [Click here for the full story.]( Cheers to Profits! [Image] Kyle Dennis P.S. Jason Bond is going LIVE on Thursday, December 19 at 12:00 PM EST to reveal his BRAND NEW strategy — [Smoke Signals]( — one that he thinks could help him reach 7 figures in trading profits in 2020. WARNING — seating for this event is extremely limited. [Click here to secure your spot.]( Kyle Dennis [Special]( RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Click Here to stop receiving emails from kyle@biotechbreakouts.com]( [Unsubscribe from all RagingBull emails]( Neither Kyle Dennis nor RagingBull.com, LLC (publisher of BiotechBreakouts) is registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. The owners, employees and writers of RagingBull.com may engage in securities trading that is discussed or viewed on this website, but all such individuals are buying and selling such securities for their own account. These individuals do not engage in any trades with customers. The buying and selling of securities by these individuals is not part of a regular business of buying and selling securities. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for RagingBull.com, LLC may have long or short positions in securities that may be discussed on this website or newsletter, but all such positions are held for such representative’s own account. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are actual figures from the portfolios Kyle Dennis manages on behalf of RagingBull.com, LLC. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.

Marketing emails from biotechbreakouts.com

View More
Sent On

31/07/2021

Sent On

31/07/2021

Sent On

17/07/2021

Sent On

09/07/2021

Sent On

08/07/2021

Sent On

08/07/2021

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.